HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edda Fiebiger Selected Research

IgE Receptors (Fc epsilon RI)

1/2012Fc-epsilon-RI, the high affinity IgE-receptor, is robustly expressed in the upper gastrointestinal tract and modulated by mucosal inflammation.
7/2011High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation.
11/2010Comparative analysis of FcεRI expression patterns in patients with eosinophilic and reflux esophagitis.
5/2010The signal peptide of the IgE receptor alpha-chain prevents surface expression of an immunoreceptor tyrosine-based activation motif-free receptor pool.
2/2009The role of the high-affinity IgE receptor, FcepsilonRI, in eosinophilic gastrointestinal diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edda Fiebiger Research Topics

Disease

12Inflammation (Inflammations)
09/2022 - 11/2002
11Hypersensitivity (Allergy)
09/2022 - 08/2004
7Neoplasms (Cancer)
09/2022 - 09/2003
3Anaphylaxis (Anaphylactic Shock)
10/2020 - 04/2015
3Eosinophilic Esophagitis
01/2018 - 05/2014
3Colitis
07/2014 - 01/2011
2Rheumatoid Arthritis
10/2020 - 08/2004
2Autoimmune Diseases (Autoimmune Disease)
10/2020 - 09/2010
2Food Hypersensitivity (Food Allergy)
10/2020 - 01/2018
1Gastroesophageal Reflux (GERD)
01/2018
1Wiskott-Aldrich Syndrome
10/2016
1Diarrhea
09/2015
1X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation
06/2015
1Crohn Disease (Crohn's Disease)
07/2014
1Eosinophilia
07/2011
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2011
1Peptic Esophagitis (Reflux Esophagitis)
11/2010
1HIV Infections (HIV Infection)
09/2010
1Obesity
09/2010
1Melanoma (Melanoma, Malignant)
06/2010
1Liposarcoma
03/2009
1Immune System Diseases (Immune Disorders)
02/2009
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2009
1Genetic Predisposition to Disease (Genetic Predisposition)
02/2009
1Multiple Myeloma
05/2005
1Hematologic Neoplasms (Hematological Malignancy)
05/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
08/2004
1Hyperplasia
08/2004
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2003
1Urticaria (Hives)
09/2002
1Chronic Urticaria
09/2002
1Familial dermographism
09/2002

Drug/Important Bio-Agent (IBA)

14Immunoglobulin E (IgE)IBA
10/2020 - 09/2002
6AllergensIBA
10/2020 - 02/2009
5IgE Receptors (Fc epsilon RI)IBA
01/2012 - 02/2009
4Messenger RNA (mRNA)IBA
01/2018 - 01/2011
3AutoantibodiesIBA
10/2020 - 09/2002
3Proteins (Proteins, Gene)FDA Link
05/2013 - 03/2009
2AntigensIBA
12/2015 - 03/2015
2Neoplasm Antigens (Tumor Antigens)IBA
03/2015 - 01/2014
2Immunoglobulins (Immunoglobulin)IBA
03/2015 - 08/2010
2Dextran SulfateIBA
07/2014 - 01/2011
2Pharmaceutical PreparationsIBA
07/2014 - 06/2010
1Pathogen-Associated Molecular Pattern MoleculesIBA
09/2022
1Immunoglobulin G (IgG)IBA
10/2020
1Histidine (L-Histidine)FDA Link
10/2020
1Proton Pump InhibitorsIBA
10/2020
1Omeprazole (Prilosec)FDA LinkGeneric
10/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Tryptases (Tryptase)IBA
01/2020
1Fc Receptors (Fc Receptor)IBA
12/2015
1Cyclic NucleotidesIBA
09/2015
1Clotrimazole (Lotrimin)FDA LinkGeneric
09/2015
1SolutionsIBA
09/2015
1Polysaccharides (Glycans)IBA
04/2015
1SaltsIBA
07/2014
1ChemokinesIBA
07/2014
1Chemokine ReceptorsIBA
07/2014
1Cholera ToxinIBA
05/2013
1Wiskott-Aldrich Syndrome ProteinIBA
09/2012
1Interleukin-10 (Interleukin 10)IBA
09/2012
1ElementsIBA
07/2011
1CytokinesIBA
01/2011
1AntioxidantsIBA
09/2010
1Glutathione (Reduced Glutathione)IBA
09/2010
1erythromycin propionate-N-acetylcysteinateIBA
09/2010
13,3',4,4',5,5'-hexahydroxystilbeneIBA
06/2010
1StilbenesIBA
06/2010
1CCAAT-Enhancer-Binding ProteinsIBA
03/2009
1Peptides (Polypeptides)IBA
03/2009
1Phosphotransferases (Kinase)IBA
03/2009
1Carrier Proteins (Binding Protein)IBA
03/2009
1Guanine NucleotidesIBA
03/2009
1Deubiquitinating EnzymesIBA
03/2009
1Proteasome InhibitorsIBA
05/2005
1Bortezomib (Velcade)FDA Link
05/2005
1Boronic AcidsIBA
05/2005
1DipeptidesIBA
05/2005
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2004
1Biological ProductsIBA
08/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2004
1Blocking AntibodiesIBA
08/2004
1EpitopesIBA
09/2003
1EnzymesIBA
11/2002
1Histamine (Histamine Dihydrochloride)FDA Link
09/2002
1anti-IgE antibodiesIBA
09/2002
1Cholinergic Agents (Cholinergics)IBA
09/2002

Therapy/Procedure

7Therapeutics
09/2022 - 09/2010
1Fluid Therapy (Oral Rehydration Therapy)
09/2015